Last reviewed · How we verify

WR279,396 with Tegaderm Dressing

U.S. Army Medical Research and Development Command · Phase 2 active Small molecule

At a glance

Generic nameWR279,396 with Tegaderm Dressing
SponsorU.S. Army Medical Research and Development Command
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: